Latest in Tag: Gilead Highlight
Latest in Tag: Gilead
American “Gilead Sciences” considers producing new Hepatitis C drug in Egypt
The new drug’s cure rate is 98%, and treatment period is two months: company’s director in Africa
Egypt closes deal with Gilead Sciences for Hepatitis C drug at 99% discount
Around 170,000 doses of Hepatitis C medicine will be available for Egyptian patients late September
Unaware of pesticide danger, Rural Egyptians put their health at risk
A study conducted in two villages indicates that most don’t know how to protect themselves against hepatitis C and the adverse health effects of pesticides
Gilead offers Egypt new hepatitis C drug at 99% discount
While the drug will still cost $900 for a 12-week course of treatment, that is a fraction of the $84,000 charged for a course of treatment in the United States.